← Open Payments lookup

MEAGAN CHAVARRIA: Open Payments

NPI 1467843086 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,407 in 128 payments from 20 companies in 2025. Trend: 2023 $1,556 · 2024 $6,523 · 2025 $12,407

Speaker / faculty: $4,410Travel & lodging: $4,223Food & beverage: $2,100Consulting: $1,674
CompanyPaymentsAmount
Merck Sharp & Dohme LLC20$7,876
Actelion Pharmaceuticals US, Inc.21$2,286
United Therapeutics Corporation25$902
Bayer Healthcare Pharmaceuticals Inc.7$259
Baxter Healthcare16$233
Grifols USA, LLC8$196
Insmed, Inc.5$103
Boehringer Ingelheim Pharmaceuticals, Inc.3$89
AstraZeneca Pharmaceuticals LP5$88
Astellas Pharma US Inc2$59

Products named: WINREVAIR, UPTRAVI, Tyvaso, Adempas, Hillrom - Vest System Model 105 Home Care, Prolastin-C Liquid, OPSUMIT, Arikayce.

Industry payments across TX — which companies pay providers there.